Onivyde
(irinotecan)10 ML irinotecan hydrochloride liposome 4.3 MG/ML Injection [Onivyde]
Dosage & administration
biomarker testing
Onivyde clinical details
Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.
drug label
Onivyde prescribing information
financial assistance
Onivyde financial assistance options
Co-pay savings program
commercial only
Learn More
Foundation programs
under insured
no insurance
goverment insurance
65+
Learn More
patient education
Onivyde patient education
Getting started on Onivyde
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link
Patient toolkit
Learn More
Other resources
Learn More
people also ask
Onivyde FAQs
How is the dosage of Onivyde?Onivyde is available in 1 dosages, including 4.3 mg/ml Injection 10 ml
What does Onivyde treat?Onivyde treats Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Colonic Neoplasms, Leukemia, Lymphoma, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms and Stomach Neoplasms
What is Onivyde made of?Onivyde contains irinotecan which is a Topoisomerase Inhibitor
How Is Onivyde Administered?Onivyde is administered as a Injectable
What Are The Onivyde Mechanism Of Action?Onivyde mechanism of action is Topoisomerase Inhibitors
FAQ Data Source